×
About 40,870 results

ALLMedicine™ Antiretroviral Therapy Center

Research & Reviews  14,711 results

Determinants of Disclosure, Adherence and Viral Suppression in Children and Adolescents...
https://doi.org/10.1097/INF.0000000000003458
The Pediatric Infectious Disease Journal; García-Boyano M, Chávez-Solórzano N et. al.

Jan 15th, 2022 - Studies on HIV disclosure and adherence among children performed in Latin America are anecdotal. We aimed to assess the factors associated with HIV disclosure, adherence and viral suppression among Ecuadorian children and compare the psychological...

Comparative Outcomes for Mature T and NK/T-cell Lymphomas in People with and without HI...
https://doi.org/10.1182/bloodadvances.2021006208
Blood Advances; Koh MJ, Merrill MH et. al.

Jan 14th, 2022 - There are no studies comparing the prognosis for mature T-cell lymphoma (TCL) in people with human immunodeficiency virus (PWH) to people without HIV (PWoH) and to AIDS-defining B-cell lymphomas (A-BCL) in the modern antiretroviral therapy (ART) e...

Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adu...
https://doi.org/10.1111/hiv.13230
HIV Medicine; Affi R, Gabillard D et. al.

Jan 14th, 2022 - We report the association between pre-antiretroviral therapy (pre-ART) soluble vascular cell adhesion molecule-1 (sVCAM-1) levels and long-term mortality in HIV-infected West African adults participating in a trial of early ART in West Africa (Tem...

see more →

Guidelines  25 results

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Reco...
https://doi.org/10.1001/jama.2020.17025
JAMA Saag MS, Gandhi RT et. al.

Oct 15th, 2020 - Data on the use of antiretroviral drugs, including new drugs and formulations, for the treatment and prevention of HIV infection continue to guide optimal practices. To evaluate new data and incorporate them into current recommendations for initia...

2019 update of the European AIDS Clinical Society Guidelines for treatment of people li...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754379
HIV Medicine; Ryom L, Cotter A et. al.

Sep 5th, 2020 - The European AIDS Clinical Society (EACS) Guidelines cover key aspects of HIV management with major updates every two years. The 2019 Guidelines were extended with a new section focusing on drug-drug interactions and other prescribing issues in pe...

Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a pos...
https://doi.org/10.1007/s00198-018-4794-0
Osteoporosis International : a Journal Established as Res... Biver E, Calmy A et. al.

Jan 4th, 2019 - Life expectancy of people living with HIV (PLWH) is reaching similar length as in the general population. Accordingly, age-related comorbidities, including osteoporosis, are increasing. Fracture risk is higher and increases approximately 10 years ...

ACOG Committee Opinion No. 751 Summary: Labor and Delivery Management ofWomenWith Human...
https://doi.org/10.1097/AOG.0000000000002821
Obstetrics and Gynecology;

Aug 23rd, 2018 - This Committee Opinion is being revised to provide updated guidance on the management of pregnant women during pregnancy and delivery to prevent mother-to-child transmission of the human immunodeficiency virus (HIV). Prevention of transmission of ...

ACOG Committee Opinion No. 752 Summary: Prenatal and Perinatal Human Immunodeficiency V...
https://doi.org/10.1097/AOG.0000000000002829
Obstetrics and Gynecology;

Aug 23rd, 2018 - Given the enormous advances in the prevention of perinatal transmission of human immunodeficiency virus (HIV), it is clear that early identification and treatment of all pregnant women with HIV is the best way to prevent neonatal infection and als...

see more →

Drugs  36 results see all →

Clinicaltrials.gov  566 results

Pharmacokinetics of SAR441236
https://clinicaltrials.gov/ct2/show/NCT03705169

Jan 13th, 2022 - This study will evaluate the safety, tolerability, pharmacokinetics, and antiviral activity of SAR441236, a tri-specific broadly neutralizing antibody against HIV. The study includes three arms. In Arm A, three cohorts of antiretroviral-treated, v...

HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS)
https://clinicaltrials.gov/ct2/show/NCT02437110

Jan 13th, 2022 - Objective: In this Phase I, proof-of-concept study, we aim to determine whether an antiretroviral regimen approved to treat human immunodeficiency virus (HIV) infection would also suppress levels of Human Endogenous Retrovirus-K (HERV-K) found to ...

Clinical Outcomes of People Who Acquired HIV in Early Life
https://clinicaltrials.gov/ct2/show/NCT01656564

Jan 12th, 2022 - Background: Antiretroviral therapy (ART) has altered the natural history of HIV disease in children. Long-term survivors of pediatric HIV infection offer a tremendous opportunity to understand the effects of HIV and ART health outcomes. A thorough...

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Primary and Chronic HIV-Infected Patients
https://clinicaltrials.gov/ct2/show/NCT00039689

Jan 12th, 2022 - HIV infection is known to cause profound and irreversible dysfunction of both innate and adaptive arms of the immune system. However, there is mounting evidence that early and aggressive treatment with antiretroviral drugs can prevent loss of immu...

Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy
https://clinicaltrials.gov/ct2/show/NCT05187429

Jan 11th, 2022 - This study consists of 2 Parts. Part 1 is a dose escalation phase. This phase is open-label, single dose titration study in adult people living with HIV. There are 3 stages: a screening stage of up to 14 days; on study study treatment stage, where...

see more →

News  1,008 results

Fauci: HIV Advances 'Breathtaking,' But Steadfast Focus on Disparities Needed
https://www.medscape.com/viewarticle/964139

Dec 3rd, 2021 - Dr Anthony S. Fauci Decades before becoming the go-to authority in the US on the COVID-19 global pandemic, Anthony S. Fauci, MD, found himself witnessing the earliest perplexing cases of what would become another devastating global pandemic — HIV/...

Sex Disparity Mars Rollout of Embattled HIV Treatment in Poorer Countries
https://www.medpagetoday.com/hivaids/hivaids/95942

Nov 30th, 2021 - In low- and middle-income countries, dolutegravir (Tivicay) uptake in women still trailed that in men months after a safety reaffirmation from the World Health Organization (WHO), a large study showed. By March 2020, cumulative incidence of uptake...

People Living with HIV Are at Risk of Multiple Comorbidities
https://www.medscape.com/viewarticle/963299

Nov 19th, 2021 - Takeaway People living with HIV (PLHIV) in the UK had an increased risk of developing multiple comorbid conditions. Why this matters The findings emphasise the importance of regular reviews for PLHIV to monitor the development of comorbidities in ...

'Esperanza Patient' Offers Hope for a Sterilizing HIV-1 Cure
https://www.medscape.com/viewarticle/962997

Nov 16th, 2021 - NEW YORK (Reuters Health) - A young woman from Esperanza, Argentina, may be the first to clear HIV-1 naturally without stem cell transplantation, raising hopes that a "sterilizing cure" may be an "extremely rare but possible" outcome of HIV-1 infe...

Year in Review: HIV
https://www.medpagetoday.com/hivaids/hivaids/95613

Nov 12th, 2021 - Long-acting therapies headlined a year of continued drug development, both in the treatment and prevention of HIV. Meanwhile, CDC recommended a third dose of a COVID-19 mRNA vaccine for certain patients living with advanced or untreated HIV to boo...

see more →

Patient Education  2 results see all →